A comparative analysis of methodological practices used in capture–recapture population size estimation: opioid use disorder prevalence in New York State, 2020
Open Access
- 10 July 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (11) , 2950-2958
Abstract
Prevalence estimates for opioid use disorder (OUD) are essential for guiding investments in prevention and treatment. Previous estimates have been produced using modeling approaches including capture–recapture (CRC). Empirical evaluations of CRC are needed to assess population size impacts of methodological practices utilized. We linked administrative data sources including New York State (NYS) adults with OUD by indication between January 1 and December 31, 2020 and applied Bayesian CRC methods to evaluate how methodological practices impact OUD prevalence: (1) using sensitive vs specific case definition characteristics to identify OUD, (2) including vs excluding inferred referrals from emergency medical services to healthcare settings, and (3) including vs excluding overdose mortality as a source list. We estimated OUD prevalence overall and by demographic characteristics and treatment coverage with medications for OUD (MOUD). Across methodological scenarios, OUD prevalence estimates ranged from 4.6% to 9.9%. The largest estimate resulted from a model in which the more sensitive OUD case definition was applied, while the smallest resulted from a model using the more specific case definition. An estimated 4.2% of NYS adults had OUD in 2020, with 20% receiving MOUD. Findings demonstrate that CRC methodological decisions can meaningfully influence OUD prevalence estimates, with recommended methodological practices provided.Keywords
Funding Information
- The National Institute on Drug Abuse (R01DA051302)
This publication has 35 references indexed in Scilit:
- Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesisDrug and Alcohol Dependence, 2025
- Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal OverdoseJAMA Internal Medicine, 2024
- Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking servicesDrug and Alcohol Dependence, 2023
- The prevalence of opioid use disorder in Kentucky’s counties: A two-year multi-sample capture-recapture analysisDrug and Alcohol Dependence, 2022
- Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”International Journal of Drug Policy, 2022
- What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population sizeDrug and Alcohol Dependence Reports, 2022
- Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by SexJAMA Network Open, 2020
- Assessment of Probable Opioid Use Disorder Using Electronic Health Record DocumentationJAMA Network Open, 2020
- The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdoseDrug and Alcohol Dependence, 2020
- Log‐linear modelingWIREs Computational Statistics, 2011